Kum-Sin Jung

Title: Kum-Sin Jung: Innovator in Pharmaceutical Chemistry

Introduction

Kum-Sin Jung is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative processes in drug preparation. His work has led to advancements that benefit the pharmaceutical industry and improve therapeutic options.

Latest Patents

Kum-Sin Jung holds a patent for a process titled "Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-{(2-methyl-1H-imidazol-1-yl)methyl}-4H-carbazol-4-one." This invention describes a method for preparing pure 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one or a pharmaceutically acceptable salt thereof. The process is characterized by its simplicity and high yield, utilizing a reaction between 1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one and a 2-methylimidazole derivative in an organic solvent or a mixture of an organic solvent and water, in the presence of a halosilane compound.

Career Highlights

Kum-Sin Jung is affiliated with Hanmi Pharm. Co., Ltd., where he continues to engage in research and development. His work at Hanmi Pharm has positioned him as a key player in the pharmaceutical sector, contributing to the development of new medications and therapeutic solutions.

Collaborations

Throughout his career, Kum-Sin Jung has collaborated with esteemed colleagues, including Kwang-Ok Lee and Hee-Seock Kim. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Kum-Sin Jung's contributions to pharmaceutical chemistry through his innovative patent and collaborative efforts highlight his importance in the industry. His work continues to influence the development of new therapeutic agents, showcasing the impact of dedicated inventors in advancing healthcare solutions.